Serum transaminase determined in the emergency room predicts outcomes in patients with acute ST-segment elevation myocardial infarction who undergo primary percutaneous coronary intervention

International Journal of Cardiology

Volumn 177, Issue 2, 2014, Pages 442-447

  Moon, Jeonggeun ^a   Kang, Woongchol ^a   Oh, Pyung Chun ^a   Seo, Soon Yong ^a   Lee, Kyounghoon ^a   Han, Seung Hwan ^a   Ahn, Taehoon ^a   Shin, Eakkyun ^a  

^a Gachon University   (South Korea)

Author keywords

Hypoxic liver injury; Primary PCI; Serum transaminases; STEMI

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTIC ACID; BIOLOGICAL MARKER;

AGED; BLOOD; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTIC ACID; BIOLOGICAL MARKERS; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84913543377     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.09.002     Document Type: Article

References (21)

1. E.M. Antman, M. Hand, P.W. Armstrong, E.R. Bates, L.A. Green, and L.K. Halasyamani 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
2. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
3. P.A. Merlini, K.A. Bauer, L. Oltrona, D. Ardissino, M. Cattaneo, and C. Belli Persistent activation of coagulation mechanism in unstable angina and myocardial infarction Circulation 90 1994 61 68
4. J. Daemen, P.H. van Twisk, N. Kukreja, R.T. van Domburg, E. Boersma, and P. de Jaegere The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n = 6129) EuroIntervention 4 2009 464 474
5. T. Palmerini, G. Biondi-Zoccai, D. Della Riva, A. Mariani, M. Sabate, and M. Valgimigli Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis J Am Coll Cardiol 62 2013 496 504
6. I.S. Weisberg, and I.M. Jacobson Cardiovascular diseases and the liver Clin Liver Dis 15 2011 1 20
7. B. Vollmar, and M.D. Menger The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair Physiol Rev 89 2009 1269 1339
8. R. Birrer, Y. Takuda, and T. Takara Hypoxic hepatopathy: pathophysiology and prognosis Intern Med 46 2007 1063 1070
9. A. Kavoliuniene, A. Vaitiekiene, and G. Cesnaite Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist's point of view Int J Cardiol 166 2013 554 558
10. B.J. Hoffman, M.B. Pate, W.H. Marsh, and W.M. Lee Cardiomyopathy unrecognized as a cause of hepatic failure J Clin Gastroenterol 12 1990 306 309
11. E.C. Ebert Hypoxic liver injury Mayo Clin Proc 81 2006 1232 1236
12. S.H. Kubo, B.A. Walter, D.H. John, M. Clark, and R.J. Cody Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics Arch Intern Med 147 1987 1227 1230
13. J.E. Naschitz, G. Slobodin, R.J. Lewis, E. Zuckerman, and D. Yeshurun Heart diseases affecting the liver and liver diseases affecting the heart Am Heart J 140 2000 111 120
14. S.M. Richman, A.J. Delman, and D. Grob Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes Am J Med 30 1961 211 225
15. C.C. Giallourakis, P.M. Rosenberg, and L.S. Friedman The liver in heart failure Clin Liver Dis 6 2002 947 967 [viii-ix]
16. S. Chia, F. Senatore, O.C. Raffel, H. Lee, F.J. Wackers, and I.K. Jang Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction JACC Cardiovasc Interv 1 2008 415 423
17. C. Lazzeri, S. Valente, M. Chiostri, A. Sori, P. Bernardo, and G.F. Gensini Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience Int J Cardiol 138 2010 206 209
18. S. Sederholm Lawesson, T. Todt, J. Alfredsson, M. Janzon, U. Stenestrand, and E. Swahn Gender difference in prevalence and prognostic impact of renal insufficiency in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention Heart 97 2011 308 314
19. H. Steen, E. Giannitsis, S. Futterer, C. Merten, C. Juenger, and H.A. Katus Cardiac troponin T at 96 h after acute myocardial infarction correlates with infarct size and cardiac function J Am Coll Cardiol 48 2006 2192 2194
20. E. Giannitsis, H. Steen, K. Kurz, B. Ivandic, A.C. Simon, and S. Futterer Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T J Am Coll Cardiol 51 2008 307 314
21. J.E. Naschitz, D. Yeshurun, and J. Shahar Cardiogenic hepatorenal syndrome Angiology 41 1990 893 900